Latest Operational Efficiency News

NoviqTech launches Quantum Intelligence Pty Ltd, introducing hybrid quantum computing solutions with a $1.25 million placement to accelerate growth and product rollout.

Medical Developments International (MVP) reports positive operating cash flow in H2 FY25, driven by strong Penthrox sales and strategic distribution shifts in Europe. The company eyes further growth amid regulatory progress and efficiency gains.

InteliCare Holdings advances its AI-driven aged care platform with new trials and integrations, secures $1 million in funding, and announces CEO Daniel Pilbrow’s upcoming resignation.

FirstWave Cloud Technology reports a slight revenue decline in Q4 FY25, offsets challenges with strategic restructuring and a new AWS marketplace partnership.

HALO Technologies reports $3.54 million in Q2 revenue with rising subscription income, progressing UK expansion pending FCA approval, and a $6.75 million capital raise nearing completion.

Beacon Minerals reported a 20% increase in gold production to 7,365 ounces in the June 2025 quarter, alongside significant drilling progress at the Iguana deposit and a strategic share consolidation and buy-back program.

Imugene Limited reports strong clinical progress with its off-the-shelf CAR T therapy azer-cel achieving a 75% overall response rate in Phase 1b trials, alongside new patents and leadership appointments. The company also secured $22.5 million in fresh funding to advance pivotal trials.

Group 6 Metals Limited has reported record quarterly tungsten production and sales, completed a major recapitalisation reducing debt, and is transitioning from open cut to underground mining at its Dolphin Tungsten Mine.

Mad Paws Holding Limited reported modest revenue growth and improved cash flow in Q4 2025, while progressing a significant acquisition deal with Rover Group and divesting its Pet Chemist business.

Alma Metals has bolstered its Briggs Copper JV Project with a $1.06 million capital raise and an updated resource estimate that now includes silver. The company is progressing a scoping study and preparing for significant drilling to unlock further value.

MedAdvisor reports a significant revenue decline in FY25 amid US program delays but strengthens its balance sheet through a capital raise and ANZ business sale. The company signals a strategic pivot with potential US business divestment on the horizon.

xReality Group delivered a strong Q4 FY25 with $4.7 million in cash receipts, driven by growth in its Operator XR enterprise software and entertainment divisions, alongside a $2 million placement to institutional investors supporting international expansion.